13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001599882
申報總市值
US$10.6億
US$10.6億
92 檔
15.7%
Q3 2025 季度申報顯示，Rhenman & Partners Asset Management AB 揭露的美股組合總市值為 US$10.6億，涵蓋 92 個不同之權益投資部位。
Q3 2025 的申報記錄反映 Rhenman & Partners Asset Management AB 的板塊替換策略：機構本季推動了 62 筆增持與 49 筆減持，籌碼呈現明顯的結構重組。
檢視投資組合結構，前 5 大主力部位（包含 BSX, LLY, ABBV）占據了總市值的 15.7%，展現出該機構在 Q3 2025 的重點資金聚焦與風險分佈特徵。
本季最大新建倉標的
CAH
市值: US$1475.4萬
本季最大獲利了結 / 清倉標的
MOH
前期市值: US$2246.4萬
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSX | Boston Scientific CORP | 股票-醫療保健 | 4.73% | -3.03% | +47.97% | |
| 2 | LLY | Eli Lilly & Co | 股票-醫療保健 | 4.51% | -1.30% | -7.69% | |
| 3 | ABBV | Abbvie Inc | 股票-醫療保健 | 3.34% | +0.38% | +87.93% | |
| 4 | DHR | Danaher CORP | 股票-醫療保健 | 2.95% | +1.02% | +10.70% | |
| 5 | ALHC | Alignment Healthcare Inc | 股票-其他 | 2.86% | -0.05% | +14.92% | |
| 6 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 2.40% | -0.80% | +9.36% | |
| 7 | UNH | Unitedhealth Group Inc | 股票-醫療保健 | 2.39% | +2.15% | +105.49% | |
| 8 | AXSM | Axsome Therapeutics Inc | 股票-醫療保健 | 2.32% | +0.13% | +90.31% | |
| 9 | CVS | Cvs Health CORP | 股票-醫療保健 | 2.31% | -0.25% | -6.09% | |
| 10 | MCK | Mckesson CORP | 股票-醫療保健 | 2.27% | -0.62% | -4.03% | |
| 11 | REGN | Regeneron Pharmaceuticals | 股票-醫療保健 | 2.25% | -2.98% | +30.32% | |
| 12 | IONS | Ionis Pharmaceuticals Inc | 股票-醫療保健 | 2.24% | -0.41% | +70.33% | |
| 13 | MDT | Medtronic plc | 股票-醫療保健 | 2.16% | +0.11% | +14.21% | |
| 14 | COR | Cencora Inc | 股票-醫療保健 | 2.16% | -0.78% | +26.33% | |
| 15 | EXK | Exact Sciences CORP | 股票-原物料 | 2.11% | — | -0.57% | |
| 16 | INSM | Insmed Inc | 股票-醫療保健 | 2.10% | -1.69% | -24.82% | |
| 17 | GKOS | Glaukos CORP | 股票-醫療保健 | 2.08% | +0.45% | -2.13% | |
| 18 | VRTX | Vertex Pharmaceuticals Inc | 股票-醫療保健 | 2.03% | -0.96% | -23.59% | |
| 19 | PODD | Insulet CORP | 股票-醫療保健 | 1.98% | +0.24% | +26.09% | |
| 20 | COO | Cooper Cos Inc/the | 股票-醫療保健 | 1.80% | -0.07% | +39.41% | |
| 21 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 1.78% | -0.27% | -23.12% | |
| 22 | EHC | Encompass Health CORP | 股票-醫療保健 | 1.68% | +0.04% | -12.46% | |
| 23 | CAH | Cardinal Health Inc | 股票-醫療保健 | 1.63% | -0.20% | +70.91% | |
| 24 | TMO | Thermo Fisher Scientific Inc | 股票-醫療保健 | 1.61% | -1.02% | +169.66% | |
| 25 | ALNY | Alnylam Pharmaceuticals Inc | 股票-醫療保健 | 1.61% | -0.92% | -37.74% | |
| 26 | CYTK | Cytokinetics Inc | 股票-醫療保健 | 1.55% | — | +144.84% | |
| 27 | PRCT | Procept Biorobotics CORP | 股票-其他 | 1.54% | -0.73% | +105.26% | |
| 28 | CI | THE Cigna Group | 股票-醫療保健 | 1.48% | +0.19% | +45.31% | |
| 29 | ABT | Abbott Laboratories | 股票-醫療保健 | 1.46% | -0.60% | +68.38% | |
| 30 | JAZZ | Jazz Pharmaceuticals plc | 股票-醫療保健 | 1.39% | +0.22% | -12.84% | |
| 31 | EW | Edwards Lifesciences CORP | 股票-醫療保健 | 1.33% | +0.61% | +181.82% | |
| 32 | THC | Tenet Healthcare CORP | 股票-醫療保健 | 1.31% | +0.24% | -57.17% | |
| 33 | AKRO | Akero Therapeutics Inc | 股票-其他 | 1.21% | — | +16.70% | |
| 34 | ALGN | Align Technology Inc | 股票-醫療保健 | 1.15% | +0.84% | +24.81% | |
| 35 | BMRN | Biomarin Pharmaceutical Inc | 股票-醫療保健 | 1.12% | +0.13% | +24.72% | |
| 36 | DOCS | Doximity Inc-class A | 股票-醫療保健 | 1.10% | -0.38% | +547.62% | |
| 37 | RPRX | Royalty Pharma plc | 股票-醫療保健 | 1.01% | -0.34% | -24.85% | |
| 38 | GILD | Gilead Sciences Inc | 股票-醫療保健 | 0.98% | -0.75% | -52.33% | |
| 39 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.98% | +0.07% | — | |
| 40 | MDGL | Madrigal Pharmaceuticals Inc | 股票-醫療保健 | 0.93% | -1.14% | — | |
| 41 | BIIB | Biogen Inc | 股票-醫療保健 | 0.85% | -0.54% | +358.33% | |
| 42 | DVAX | Dynavax Technologies CORP | 股票-其他 | 0.85% | — | +36.64% | |
| 43 | ADPT | Adaptive Biotechnologies | 股票-其他 | 0.82% | -1.23% | EXIT | |
| 44 | ELV | Elevance Health Inc | 股票-醫療保健 | 0.80% | +0.10% | -49.61% | |
| 45 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.76% | -0.06% | +37.12% | |
| 46 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 0.69% | +0.18% | — | |
| 47 | CNC | Centene CORP | 股票-醫療保健 | 0.67% | +1.48% | NEW | |
| 48 | STOK | Stoke Therapeutics Inc | 股票-其他 | 0.65% | -0.13% | — | |
| 49 | VKTX | Viking Therapeutics Inc | 股票-醫療保健 | 0.63% | -0.17% | +154.46% | |
| 50 | AVR | Anteris Technologies Global | 股票-其他 | 0.62% | +0.44% | — |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | DHR | Danaher CORP | +2% | +10.70% | 加碼 |
| 2 | IONS | Ionis Pharmaceuticals Inc | +2% | +70.33% | 加碼 |
| 3 | BSX | Boston Scientific CORP | +1.3% | +47.97% | 加碼 |
| 4 | EHC | Encompass Health CORP | +1.2% | -12.46% | 加碼 |
| 5 | ABBV | Abbvie Inc | +1.2% | +87.93% | 加碼 |
| 6 | COR | Cencora Inc | +1.1% | +26.33% | 加碼 |
| 7 | CYTK | Cytokinetics Inc | +1.1% | +144.84% | 加碼 |
| 8 | TMO | Thermo Fisher Scientific Inc | +0.9% | +169.66% | 加碼 |
| 9 | AXSM | Axsome Therapeutics Inc | +0.9% | +90.31% | 加碼 |
| 10 | AKRO | Akero Therapeutics Inc | +0.8% | +16.70% | 加碼 |
| 11 | ABT | Abbott Laboratories | +0.7% | +68.38% | 加碼 |
| 12 | NBIX | Neurocrine Biosciences Inc | +0.6% | -23.12% | 加碼 |
| 13 | LLY | Eli Lilly & Co | +0.6% | -7.69% | 加碼 |
| 14 | APLSUSD | Apellis Pharmaceuticals Inc | +0.5% | +149.06% | 加碼 |
| 15 | PEN | Penumbra Inc | +0.5% | -4.65% | 加碼 |
| 16 | DNTH | Dianthus Therapeutics Inc | +0.5% | +37.12% | 加碼 |
| 17 | CVS | Cvs Health CORP | +0.5% | -6.09% | 加碼 |
| 18 | INSM | Insmed Inc | +0.5% | -24.82% | 減碼 |
| 19 | GPCR | Structure Therapeutics Inc | +0.4% | +33.31% | 加碼 |
| 20 | CI | THE Cigna Group | +0.4% | +45.31% | 加碼 |
| 21 | ALGN | Align Technology Inc | +0.4% | +24.81% | 加碼 |
| 22 | SNDX | Syndax Pharmaceuticals Inc | +0.4% | — | 加碼 |
| 23 | VKTX | Viking Therapeutics Inc | +0.4% | +154.46% | 加碼 |
| 24 | BRKR | Bruker CORP | +0.4% | +25.14% | 加碼 |
| 25 | KURA | Kura Oncology Inc | +0.3% | +96.00% | 加碼 |
| 26 | PRVA | Privia Health Group Inc | +0.3% | +112.95% | 加碼 |
| 27 | ACLXGBX | Arcellx Inc | +0.3% | -2.97% | 加碼 |
| 28 | XENE | Xenon Pharmaceuticals Inc | +0.2% | +131.43% | 加碼 |
| 29 | INSP | Inspire Medical Systems Inc | +0.2% | +100.00% | 加碼 |
| 30 | ✓ | Merus N V | +0.2% | -53.88% | 減碼 |
| 31 | ANNX | Annexon Inc | +0.2% | +78.91% | 加碼 |
| 32 | ALKS | Alkermes plc | +0.2% | +141.03% | 加碼 |
| 33 | PODD | Insulet CORP | +0.1% | +26.09% | 減碼 |
| 34 | RLAY | Relay Therapeutics Inc | +0.1% | — | 不變 |
| 35 | ALNY | Alnylam Pharmaceuticals Inc | +0.1% | -37.74% | 減碼 |
| 36 | AVR | Anteris Technologies Global | +0.1% | — | 減碼 |
| 37 | MIRM | Mirum Pharmaceuticals Inc | +0.1% | -14.45% | 減碼 |
| 38 | BIIB | Biogen Inc | +0.1% | +358.33% | 加碼 |
| 39 | NUVL | Nuvalent Inc-a | +0.1% | — | 不變 |
| 40 | RARE | Ultragenyx Pharmaceutical In | +0.1% | +28.25% | 加碼 |
| 41 | BNTX | Biontech Se-adr | 0% | — | 加碼 |
| 42 | NRIX | Nurix Therapeutics Inc | 0% | +87.84% | 加碼 |
| 43 | DVAX | Dynavax Technologies CORP | 0% | +36.64% | 加碼 |
| 44 | IOVA | Iovance Biotherapeutics Inc | 0% | +69.46% | 加碼 |
| 45 | IMCR | Immunocore Holdings Plc-adr | 0% | — | 不變 |
| 46 | ALHC | Alignment Healthcare Inc | — | +14.92% | 加碼 |
| 47 | DNLI | Denali Therapeutics Inc | — | — | 不變 |
| 48 | XNCR | Xencor Inc | 0% | — | 減碼 |
| 49 | MLTX | Moonlake Immunotherapeutics | 0% | +360.00% | 加碼 |
| 50 | IQV | Iqvia Holdings Inc | 0% | +50.00% | 減碼 |
根據 SEC 官方 Form 13F 申報備案，Rhenman & Partners Asset Management AB 在 Q3 2025 季度的美股持倉總市值約為 US$10.6億，共申報了 92 個公開持股部位。
在 Q3 2025 季度，Rhenman & Partners Asset Management AB 按市值排列的前三大核心持股分別為：BSX (4.7%)、LLY (4.5%)、ABBV (3.3%)。其中最大持股部位 BSX 佔據整體投資組合約 4.7% 的權重。
在 Q3 2025 季度中，Rhenman & Partners Asset Management AB 共進行了 111 項持倉異動，包含新建倉 21 個部位、加碼 41 個部位、減碼 26 個部位以及清倉 23 個部位。 其中最大新建倉標的為 CAH。 本季清倉部位包含 MOH。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。